Czibere Akos
Chief Medical Officer
Czibere Akos has filed 2 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Sep 24, 2026.
On the most recent filing, Czibere Akos is listed as Chief Medical Officer at Aktis Oncology, Inc. Inside the rolling window, Czibere Akos reported no open-market purchases and 2 open-market sales totaling $1.6M in AKTS. The largest disclosed transaction in the window is a sale of 50,000 AKTS shares on Jul 8, 2026, worth $1.4M.
Companies traded
Other insiders at AKTS
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.6M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Czibere Akos made?
Czibere Akos has filed 2 SEC Form 4 filings (7 transaction rows) across 1 company since 2026.
Which companies does Czibere Akos trade?
Czibere Akos has filed SEC Form 4 disclosures for 1 company, including AKTS.
When was Czibere Akos's most recent SEC Form 4 filing?
Czibere Akos's most recent SEC Form 4 filing on Tracefour is dated Sep 24, 2026.
What is Czibere Akos's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Czibere Akos is listed as Chief Medical Officer.
What is Czibere Akos's total buy and sell value in the current window?
Inside the rolling retention window, Czibere Akos bought $0 and sold $1.6M based on SEC Form 4 filings.
What was Czibere Akos's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 50,000 AKTS shares on 2026-07-08, worth $1.4M, per SEC Form 4 filings.